Rebecca
Rebecca was treated for breast cancer and has undergone surgery, chemotherapy and radiotherapy. She agreed to participate in the 100,000 Genomes Project because it is an opportunity to help to research to help people. She thinks there should be more information given to the public about the project so people are aware of it before they are asked to participate.
Rebecca was invited to take part in the 100,000 Genomes Project during the meeting with her consultant. She felt that the timing wasn’t right because she was worrying about her diagnosis of breast cancer and treatment options – as she put it: your mind is elsewhere. She was given information to read at home and she also looked online. She didn’t know about the Genomes Project before she was invited to participate and thinks that it should be better publicised in the media, social media and in GP surgeries so people in her situation are aware of it before being asked to participate. She also thinks that the project isn’t promoted enough by health professionals.
Rebecca felt that by agreeing to take part in the 100,000 Genomes Project she was doing a little to pay back for the medical research that has gone before and that she have benefited from or, as she put it: I’m having treatment on the back of other people who’ve taken medical research in the past. She says that donating tissue sample is important because it is helping identify the different types of breast cancer and helping to develop more tailored treatments. The more donations of tissue samples may help researchers identify other undiscovered types of breast cancer still. She also notes that the tissue was going to be thrown away, incinerated so it seems reasonable to keep it for research.
Rebecca hopes that medical research will help people to be screened at a younger age for genetic-related diseases. Through screening, she found out that she has the BRCA1 gene that causes breast cancer and increases the risk of ovarian cancer. Her daughter aged 21 was screened for the BRCA1 gene and tested negative. Rebecca feels that these kinds of tests are crucial to help people make life decisions like when to start a family.
Rebecca feels that Genomics England should keep in touch with people who took part in the project by sending a yearly letter with an update and news about the project. She cannot recall being told that she would receive information about her personal results.
Rebecca doesn’t have any concerns about data storage and data security, but when first told about data sharing she was alarmed to know that her samples could be used by drug companies. Later on, she changed her mind as she recognised that commercial companies could come out with new treatments that would help people.